116387-40-7

基本信息
2-氧代-5-碘-1,2-二氫-3-吡啶甲酸甲酯
5-碘-2-氧代-1,2-二氫吡啶-3-甲酸甲酯
METHYL 2-HYDROXY-5-IODONICOTINATE
2-Hydroxy-5-iodo-nicotinic acid methyl ester
Methyl 2-hydroxy-5-iodopyridine-3-carboxylate
METHYL 2-HYDROXY-5-IODONICOTINATE ISO 9001:2015 REACH
METHYL 5-IODO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBOXYLATE
Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate
2-Hydroxy-5-iodopyridine-3-carboxylic acid methyl ester
5-Iodo-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid Methyl ester
3-Pyridinecarboxylic acid, 1,2-dihydro-5-iodo-2-oxo-, methyl ester
物理化學性質
制備方法

10128-91-3

116387-40-7
以2-氧代-1,2-二氫-3-吡啶羧酸甲酯為原料合成5-碘-2-氧代-1,2-二氫吡啶-3-甲酸甲酯的一般步驟如下:在室溫條件下,將2-羥基煙酸甲酯(20g)溶解于二氯甲烷(500mL)中,隨后加入N-碘代琥珀酰亞胺(NIS,38g)。將反應混合物加熱至回流狀態(tài),持續(xù)反應16小時。反應完成后,蒸發(fā)去除溶劑。向殘余物中加入乙酸乙酯(200mL),并在回流條件下加熱2小時。反應混合物冷卻后,過濾收集不溶性固體,得到目標產物2-羥基-5-碘煙酸甲酯(30g,收率81%),為白色固體。產物經(jīng)1H NMR(300MHz,CDCl3)表征:δ3.97(s,3H),8.33(brs,1H),8.43(d,J=2.4Hz,1H)。
參考文獻:
[1] Journal of Medicinal Chemistry, 1993, vol. 36, # 18, p. 2676 - 2688
[2] Patent: EP1477186, 2004, A1. Location in patent: Page/Page column 41
[3] Patent: EP1357111, 2003, A1. Location in patent: Page/Page column 59-60
[4] Patent: US2005/203081, 2005, A1. Location in patent: Page/Page column 13
[5] Patent: WO2008/76425, 2008, A1. Location in patent: Page/Page column 54